What comes after ibogaine — and how to approach it. The neuroplasticity window, integration practices, lifestyle changes, peer support, and the ongoing self-work that makes the difference between a profound experience and a lasting one.
After the Flood is the newest and most actively growing pillar on IbogaineAdvisor. Everything below is published, built from clinical research, practitioner interviews, and the real experiences of people who've been through it. More is added as it's written and verified.
The emotional volatility, physical recovery, the afterglow period, and when to be concerned versus when to trust the process.
Read the guide →What psychedelic integration therapy is, what to look for in a practitioner, and how to actually find one — including the honest reality that supply is thin.
Read the guide →Non-response is real. How to honestly assess outcomes, what options exist, and what practitioners recommend when ibogaine doesn't deliver the expected shift.
Read the guide →What the research says about protecting and extending ibogaine's effects through the 6–8 weeks after treatment.
Read the guide →A vetted guide to the communities, groups, and ongoing support resources available to ibogaine alumni.
Read the guide →Somatic work, journaling, breathwork, psychotherapy: what each modality offers and what the evidence says about integrating them with psychedelic experiences.
Read the guide →Deciding, preparing, choosing a program, and what happens in the room. Everything you need before you go.
Explore The Experience →Honest, firsthand accounts from people who have been through ibogaine treatment. What the months and years afterward actually looked like, in their own words.
Explore Perspectives →Understanding what happened in the room — the mechanism, the visionary content, the physical effects — is part of how you make meaning from it afterward.
Read the guide →What six-month and one-year follow-up data shows about ibogaine's lasting effects — and what predicts who maintains their gains.
Read the research →New Path Ibogaine's clinical director on why most programs get the emphasis backwards — and what they've learned from watching hundreds of patients over more than a decade.
Read the interview →